# Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic Dermatitis

> **NCT03846466** · PHASE1 · TERMINATED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 5 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** KHK4323 IV/S
- **DRUG:** KHK4323 SC/S
- **DRUG:** KHK4323 IV/M
- **DRUG:** Placebo IV/S
- **DRUG:** Placebo IV/M
- **DRUG:** Placebo SC/S

## Key facts

- **NCT ID:** NCT03846466
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-02-22
- **Primary completion:** 2019-12-11
- **Final completion:** 2019-12-11
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** The study terminated for safety reasons.
- **Last updated:** 2020-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03846466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03846466, "Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic Dermatitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03846466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*